logo

biotechnology & drugs News

Share

AstraZeneca Says Forxiga Approved In EU For Treatment Of Symptomatic Chronic Heart Failure

Roche Reports Positive Results From Phase 3 COMMODORE 2 Study, Evaluating Efficacy And Safety Of Crovalimab